A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.

about

Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.

P2860

Q50992476-CC3EAA05-CD18-4F3E-9132-FE66819E1DDC

P2860

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.

Item

http://www.wikidata.org/entity/Q42139903

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A new therapeutic approach to ...... high affinity agonist ligands.

@en

A new therapeutic approach to ...... high affinity agonist ligands.

@nl

type

Item

label

A new therapeutic approach to ...... high affinity agonist ligands.

@en

A new therapeutic approach to ...... high affinity agonist ligands.

@nl

prefLabel

A new therapeutic approach to ...... high affinity agonist ligands.

@en

A new therapeutic approach to ...... high affinity agonist ligands.

@nl

P1476

A new therapeutic approach to ...... high affinity agonist ligands.

@en

P2093

Emma Mitidieri

http://www.w3.org/2001/XMLSchema#string

Erminia Donnarumma

http://www.w3.org/2001/XMLSchema#string

Giuseppe Cirino

http://www.w3.org/2001/XMLSchema#string

Giuseppe De Rosa

http://www.w3.org/2001/XMLSchema#string

Nicola Longo

http://www.w3.org/2001/XMLSchema#string

Paolo Grieco

http://www.w3.org/2001/XMLSchema#string

P2860

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation

Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Urotensin II, from fish to human

Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

Endogenous urotensin II selectively modulates erectile function through eNOS

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity.

Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation

P304

81-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1008-682X.133322

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberta d'Emmanuele Di Villa Bianca

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264430150

http://www.w3.org/2001/XMLSchema#string

P698

25080929

http://www.w3.org/2001/XMLSchema#string

P932

4291883

http://www.w3.org/2001/XMLSchema#string

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.

about

P2860

P2860

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932